HRA PHARMA ANNOUNCES INTERNATIONAL EXPANSION
· HRA Pharma, owners of Compeed®, the number one for blister and scar care in Europe, have announced their expansion into the Middle East.
· After conducting comprehensive and exciting market research, HRA Pharma highlighted a gap in the Middle Eastern market for specialist blister plasters, and have confirmed Compeed’s expansion into the UAE and Kuwait with Saudi Arabia and more countries in the region to come soon.
· David Wright, CEO of HRA Pharma, says, “Our expansion into the Middle East marks a milestone moment in the growth of HRA Pharma as we introduce Compeed® to new markets.”
Consumer healthcare company HRA Pharma will be expanding internationally into the Middle East, with the UAE and Kuwait being the first movers with the iconic footcare care brand Compeed®. HRA Pharma are number one in blister care and emergency contraception in Europe, offering superior products including, ellaOne® and NorLevo®.
The study, which over 1000 male and female participants took part in, explored the use of Compeed® in Saudi Arabia and the UAE, and lead to the exciting decision to expand into the Middle East.
Martina Gripp, Head of Marketing for DACH, Africa and the Middle East, says, “Our research revealed that there is a gap for Compeed®, the leader of specialist blister plasters, in the Middle Eastern market. Whilst we will be distributing our products in the UAE and Kuwait in the new year, we’re not stopping there.”
David Wright, CEO of HRA Pharma, says, “Expanding into the UAE and Kuwait is a fantastic achievement, demonstrating HRA Pharma’s commitment in supplying customers with the best quality products.”
Editor Details
-
Company:
- HRA Pharma
-
Name:
- HRA Pharma